Indanazoline |
| Catalog No.GC34030 |
L'indanazoline (en tant que substance active monochlorhydrate de Farial) se caractérise par une action vasoconstrictrice prononcée.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 40507-78-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Indanazoline (as monohydrochloride active substance of Farial) is characterized by a pronounced vasoconstrictive action.
In animal experiments the new imidazoline derivative indanazoline (as monohydrochloride active substance of Farial) is characterized by a pronounced vasoconstrictive action after local or intravenous application[1].
[1]. Kretzschmar R, et al. [Pharmacology of N-(2-imidazolin-2-yl)-N-(4-indanyl)amino (indanazoline), a new vasoconstrictive imidazoline compound]. Arzneimittelforschung. 1980;30(10):1746-60.
Average Rating: 5 (Based on Reviews and 8 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *